Q32 Bio/$QTTB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Q32 Bio
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Ticker
$QTTB
Sector
Primary listing
Employees
24
Headquarters
Website
Q32 Bio Metrics
BasicAdvanced
$85M
2.40
$2.42
-
-
Price and volume
Market cap
$85M
52-week high
$7.80
52-week low
$1.35
Average daily volume
218K
Financial strength
Current ratio
4.852
Quick ratio
4.306
Long term debt to equity
20.031
Total debt to equity
36.521
Interest coverage (TTM)
15.37%
Profitability
EBITDA (TTM)
17.293
Gross margin (TTM)
64.35%
Net profit margin (TTM)
55.49%
Operating margin (TTM)
31.45%
Revenue per employee (TTM)
$2,240,000
Management effectiveness
Return on assets (TTM)
13.71%
Return on equity (TTM)
125.06%
Valuation
Price to earnings (TTM)
2.399
Price to revenue (TTM)
1.33
Price to book
1.78
Price to tangible book (TTM)
1.78
Price to free cash flow (TTM)
-2.131
Free cash flow yield (TTM)
-46.94%
Free cash flow per share (TTM)
-2.727
Growth
Earnings per share change (TTM)
-136.81%
3-year revenue growth (CAGR)
100.66%
3-year earnings per share growth (CAGR)
-26.48%
What the Analysts think about Q32 Bio
Majority rating from 3 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Q32 Bio stock?
Q32 Bio (QTTB) has a market cap of $85M as of March 19, 2026.
What is the P/E ratio for Q32 Bio stock?
The price to earnings (P/E) ratio for Q32 Bio (QTTB) stock is 2.4 as of March 19, 2026.
Does Q32 Bio stock pay dividends?
No, Q32 Bio (QTTB) stock does not pay dividends to its shareholders as of March 19, 2026.
When is the next Q32 Bio dividend payment date?
Q32 Bio (QTTB) stock does not pay dividends to its shareholders.
What is the beta indicator for Q32 Bio?
Q32 Bio (QTTB) does not currently have a Beta indicator.